Distribution of company announcements to the professional platforms, finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems.
Kitron ASA (OSL:KIT) Phadia develops, manufactures and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. For a new generation of analysis instruments Kitron is the chosen partner.
Kitron has taken complete responsibility for the development, industrialisation and manufacturing. From a prototype Kitron has taken care of industrial design, mechanical construction and has developed the hardware and software. Shortly the products will be put into manufacturing and be launched in the market.
"By choosing one supplier for the complete process we have shortened time-to-market and minimised the risks that always arise in connection with market introductions" says Mats Engblom at Phadia. "We have now come a long way in the process and look forward to the first manufactured units.
After a thorough qualification process, we are of course very pleased to have been chosen as Phadia's new supplier. We had both wide and relevant technological knowhow and expertise in addition to long experience in the medical equipment industry" says Johan Sandstedt, Business Development Manager in Kitron AB
Kitron Kitron is one of Scandinavia's leading companies in development, industrialisation and manufacturing of electronics for the Data/Telecom, Defence/Marine, Medical equipment and Industry sectors. The company is located in Norway, Sweden and Lithuania. Kitron had a revenue of about NOK 1.9 billion in 2007 and has about 1,400 employees. www.kitron.com
Phadia Phadia (earlier Pharmacia Diagnostics) is a world-leader in allergy IgE testing. The products are used in seven out of ten laboraties worldwide, more than 3000 laboratories in 60 different countries. Phadias headquarter and the Swedish marketing company is located in Uppsala, Sweden. Here they conduct research and development, manufacturing and distribution within the area of allergy diagnostics.
This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
